Guduchi (Giloy) Dosage: Immunity Evidence & Safety

Guduchi — also spelled giloy — is Ayurveda's famous "Amrita," the "nectar of immortality" (Tinospora cordifolia), prescribed for centuries as an immunomodulator, antipyretic, and detoxifier. It surged back into the spotlight during the pandemic, when many people took it daily "for immunity" — and then doctors started seeing a troubling signal: cases of liver injury linked to prolonged, high-dose use. This guide maps what the human trials actually used, what "immunity" evidence really exists, and where the safety lines are.

What Guduchi Is (and What "Immunomodulator" Means Here)

Guduchi (Tinospora cordifolia, Hindi: giloy) is a climbing shrub whose stems and roots are used in Ayurveda — Amrita in the classical texts, a Rasayana (rejuvenative) prescribed for fever, infection, arthritis, and "improving resistance." The proposed immunologically active constituents include berberine-type alkaloids, glycosides (cordifolioside A — listed in the Saha & Ghosh 2012 review for macrophage phagocytic activity), and immunologically active polysaccharides — the G1-4A fraction isolated from the stem has been reported to activate macrophages and induce IL-1 secretion in mice (Saha & Ghosh 2012, Anc Sci Life 31(4):151–159; PMID 23661861).

"Immunomodulator" — not "immune booster" — is the honest term. The evidence suggests guduchi modulates immune-cell activity rather than simply cranking it up. That distinction matters, because the people who should avoid it (autoimmune conditions, transplant recipients on immunosuppressants) are exactly the ones for whom an immunostimulant could be harmful.

What the Human Evidence Says About Immunity

Here is the honest picture: guduchi has a centuries-long traditional record but only a handful of small human trials with direct immune outcomes. Most of the "immunity" literature is animal work or small clinical studies on related outcomes (fever, rhinitis, wound healing). Treat guduchi as "traditionally used + biologically plausible + small-trial supportive," not proven.

The allergic-rhinitis RCT. The strongest immune-adjacent trial: a randomized, double-blind, placebo-controlled study of 75 adults with allergic rhinitis (71 completed), using a standardized aqueous stem extract — 300 mg tablets taken three times daily for 8 weeks. The guduchi group reported greater improvement in sneezing, nasal discharge, nasal obstruction, and nasal itching than placebo. A few participants reported nasal pain or headache. The trial was small and short — suggestive for symptom relief, not broad immune protection. (Badar et al., J Ethnopharmacol 2005;96(3):445–449; PMID 15619563.)

The HIV trial. A randomized, double-blind, placebo-controlled trial gave 68 people living with HIV a T. cordifolia extract (or placebo) for 6 months. More extract recipients reported relief from disease-associated symptoms, but objective lab measurements (including CD4-cell outcomes) did not consistently show the claimed immunological benefit. This trial does not support using guduchi as an HIV treatment or as a substitute for antiretroviral therapy. (Kalikar et al., Indian J Pharmacol 2008;40(3):107–110; PMID 20040936 — 300 mg three times daily for 6 months; CD4 outcomes did not differ significantly between groups.)

The children open-label RCT. Sharma et al. (2015, JPHYTO 4(4):227–230) ran an open-label, placebo-controlled RCT in 400 children aged 1–15 years (200 per arm): guduchi was given at 100 mg/kg body weight twice daily with honey for 2 months, with total leucocyte count, lymphocyte percentage, and absolute lymphocyte count as outcomes. It reported immunomodulatory effects — but it was open-label (no blinding), pediatric, and the dose (100 mg/kg twice daily) is very high relative to adult supplement doses. (Sharma & Sharma, J Phytopharmacol 2015;4(4):227–230; DOI 10.31254/phyto.2015.4408 — 100 mg/kg twice daily confirmed verbatim in the paper; TLC, lymphocyte %, and absolute lymphocyte count improved vs placebo, all P<0.001.)

Surgical-outcome neutrophil studies. In patients with malignant obstructive jaundice, adding guduchi (16 mg/kg/day orally during biliary drainage) normalized neutrophil phagocytic and intracellular-killing capacity that remained suppressed with conventional management alone; post-operative survival was higher in the guduchi group (92.4% vs 40%, p<0.01). These are small, old, highly specific studies — supportive of immunomodulatory plausibility, not general immunity claims. (Rege et al., Indian J Gastroenterol 1993;12(1):5–8; PMID 8330924 — n=30, 16 mg/kg/day during biliary drainage.)

The bottom line: No trial shows guduchi prevents colds, flu, or infections in healthy adults. The closest evidence is the allergic-rhinitis symptom trial (900 mg/day, 8 weeks) and immune-cell markers in small studies. "Supports immune function" is a reasonable soft claim; "boosts immunity against infections" is not supported.

Guduchi Dosage for Immunity: What the Studies Used

Dosing is triangulated from the small trials, Ayurvedic monographs, and manufacturer labels — there is no established clinical dose for immunity:

A practical starting approach (not a clinical recommendation): a standardized stem extract at 250–500 mg twice daily with food, or one cup of stem decoction daily per the site's remedy page — and cycles, not continuous use (see Safety). Do not exceed the site's own caution threshold: prolonged intake above 5 g/day has been linked to liver injury.

Standardization: What to Look For on the Label

Guduchi has no dominant consumer standardization benchmark comparable to bacopa's bacosides:

• Standardized extract of stem with stated extract ratio (e.g., 5:1, 10:1) or marker compounds (cordifoliosides, berberine content) is preferable to unstandardized powder.
• Stem-only products — classical use is primarily the stem; some extracts use whole plant.
• Avoid products that list only "giloy 500 mg" with no extraction or standardization claim.

How Long Until It Works

No trial gives an onset timeline for "immunity":

• Symptom relief: The rhinitis trial measured improvement over 8 weeks — a gradual, cumulative effect, not a day-1 response.
• Immune markers: Neutrophil-function improvements in the surgical studies appeared over weeks of continuous dosing.
• Traditional framing: As a Rasayana, guduchi is meant for sustained, cycled use — but see Safety: the liver-injury signal argues against long continuous courses.

A reasonable expectation frame: 4–8 weeks of consistent use before judging anything, with breaks between courses — and no expectation of "not getting sick" from any trial.

Guduchi vs Other Immune Herbs (Quick Comparison)

Guduchi's niche is Ayurvedic tradition plus a plausible immunomodulatory mechanism — but for evidence of respiratory-illness protection, echinacea and elderberry have more directly relevant (still modest) trial data.

Side Effects & Safety: Who Should Avoid It

This is the section that matters most — guduchi's post-2020 liver signal is real:

• Liver injury with prolonged/high-dose use. The site's own remedy page warns: prolonged intake above 5 g/day has been linked to liver toxicity (DILI). A 2022 case series reported 43 patients with liver injury associated with T. cordifolia consumption (hepatocellular pattern, some with autoimmune-like features), and the herb was on hepatology radar during the COVID-era surge in use. Do not take guduchi continuously for months; cycle breaks are mandatory. Anyone with liver disease should avoid it or use only with medical supervision — and stop immediately if jaundice, dark urine, or right-upper-quadrant pain develops. (Kulkarni et al., Hepatology Communications 2022;6(6):1289–1300; PMID 35037744 — n=43 analyzed; hepatocellular pattern; AIH-like histology; RUCAM probable in 67.4%. Note: the link is disputed in India — the Ministry of Ayush has questioned botanical attribution — and formal drug-induced-AIH criteria were met in only a subset of biopsied cases.)
• Autoimmune conditions — avoid. Guduchi may stimulate immune activity; the site's own page says avoid in autoimmune conditions (rheumatoid arthritis, lupus, MS).
• Blood sugar lowering. May lower blood sugar — monitor closely if taking diabetes medications. One 6-month RCT of T. cordifolia as add-on therapy in type 2 diabetes (500 mg three times daily) reported significant glucose lowering with no hypoglycemia events recorded; claims of dangerous hypoglycemia at very high doses are not documented in the primary literature (the site's own page repeats the warning without citation).
• Pregnancy and breastfeeding. There is not enough reliable information to know whether guduchi is safe in pregnancy or breastfeeding — avoid unless a clinician approves. (NCCIH, LiverTox, and MSKCC carry no guduchi page with pregnancy guidance; WebMD's Tinospora monograph likewise advises avoiding use when pregnant or breastfeeding.)
• Surgery. Stop at least 2 weeks before a scheduled surgery — the Natural Medicines/WebMD monograph cites blood-sugar interference as the reason — and confirm with your surgeon.
• Interactions. Theoretical interactions with immunosuppressants (may counteract them) and diabetes drugs (additive blood-sugar lowering) — consult a clinician or pharmacist. Avoid combining guduchi with hepatotoxic drugs, since the herb itself has published case reports of liver injury.
• Other side effects: constipation at high doses is reported only in Ayurvedic sources (no clinical-trial evidence); mild GI upset in some users.

Dosage Summary Table

📢 Disclaimer: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any new supplement. Sources are linked for verification.

Explore the Full Remedy Database

Browse 500+ organic alternatives for health, wellness, and natural living.